NL194430C - Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking. - Google Patents

Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking. Download PDF

Info

Publication number
NL194430C
NL194430C NL9020008A NL9020008A NL194430C NL 194430 C NL194430 C NL 194430C NL 9020008 A NL9020008 A NL 9020008A NL 9020008 A NL9020008 A NL 9020008A NL 194430 C NL194430 C NL 194430C
Authority
NL
Netherlands
Prior art keywords
compound
fluorouracil
prepared
test
inflammation
Prior art date
Application number
NL9020008A
Other languages
English (en)
Dutch (nl)
Other versions
NL9020008A (nl
NL194430B (nl
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL9020008A publication Critical patent/NL9020008A/nl
Publication of NL194430B publication Critical patent/NL194430B/xx
Application granted granted Critical
Publication of NL194430C publication Critical patent/NL194430C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL9020008A 1989-01-05 1990-01-04 Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking. NL194430C (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP101789 1989-01-05
JP101789 1989-01-05
JP12209189 1989-05-15
JP12209189 1989-05-15
JP9000015 1990-01-04
PCT/JP1990/000015 WO1990007334A1 (fr) 1989-01-05 1990-01-04 Agent carcinostatique non injecte permettant de supprimer l'inflammation due a 5-fluorouracil, et procede de traitement du cancer

Publications (3)

Publication Number Publication Date
NL9020008A NL9020008A (nl) 1990-12-03
NL194430B NL194430B (nl) 2001-12-03
NL194430C true NL194430C (nl) 2002-04-04

Family

ID=26334169

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9020008A NL194430C (nl) 1989-01-05 1990-01-04 Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.

Country Status (7)

Country Link
US (1) US5116600A (fr)
EP (1) EP0443028B1 (fr)
KR (1) KR0133555B1 (fr)
DE (1) DE69003670T2 (fr)
GB (1) GB2239599B (fr)
NL (1) NL194430C (fr)
WO (1) WO1990007334A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001453A1 (fr) * 1990-07-19 1992-02-06 Otsuka Pharmaceutical Co., Ltd. Preparation solide
ES2124257T4 (es) * 1991-05-27 2012-03-23 Taiho Pharmaceutical Co., Ltd. Composición, método y equipo para la estimulación de la actividad antitumoral y para el tratamiento de tumores.
US5270042A (en) * 1993-02-23 1993-12-14 Juanita Whitham Medicinal salve composition
US5627187A (en) * 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
CA2471509A1 (fr) * 2002-01-14 2003-07-17 Novartis Ag Combinaisons comprenant des epothilones et des antimetabolites
US9611227B2 (en) 2003-03-14 2017-04-04 Taiho Pharmaceutical Co., Ltd. Antitumor effect potentiator and antitumor agent
PT1750703E (pt) * 2004-04-29 2012-02-23 Taiho Pharmaceutical Co Ltd Processo destinado à redução da toxicidade gastrintestinal devida à administração de tegafur
CN100459982C (zh) * 2004-08-30 2009-02-11 鲁南制药集团股份有限公司 去氧氟尿苷的分散片剂型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50111420A (fr) * 1974-02-16 1975-09-02
JPS5511420A (en) * 1978-07-07 1980-01-26 Tokyo Shibaura Electric Co Electric door safety of elevator
JPS55111420A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Antitumorigenic agent
EP0323441B1 (fr) 1984-10-30 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Dérivés de 5-fluorouracile
JPS63201127A (ja) 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd ５−フルオロウラシル誘導体を含有する制癌剤
DK169520B1 (da) 1986-07-25 1994-11-21 Otsuka Pharma Co Ltd 5-fluoruracilderivater, fremgangsmåde til deres fremstilling, anticancerpræparat indeholdende et sådant derivat og anvendelse af et sådant derivat til fremstilling af et præparat til behandling af cancer

Also Published As

Publication number Publication date
DE69003670T2 (de) 1994-01-27
NL9020008A (nl) 1990-12-03
NL194430B (nl) 2001-12-03
EP0443028B1 (fr) 1993-09-29
GB2239599A (en) 1991-07-10
EP0443028A4 (fr) 1991-05-30
US5116600A (en) 1992-05-26
DE69003670D1 (de) 1993-11-04
GB9019705D0 (en) 1990-11-28
KR0133555B1 (ko) 1998-04-23
WO1990007334A1 (fr) 1990-07-12
GB2239599B (en) 1992-08-26
KR910700051A (ko) 1991-03-13
EP0443028A1 (fr) 1991-08-28

Similar Documents

Publication Publication Date Title
HU211987A9 (en) Composition, method and kit for potentiating antitumor activity and for curing tumor
WO2007149285A2 (fr) Procédé servant à améliorer la diurèse chez des individus atteints d'une détérioration de la fonction rénale
JP2001513506A (ja) タイプｉｉ糖尿病のクロム／ビオチン治療
NL194430C (nl) Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
RU2367442C2 (ru) Способ нормализации мочеиспускания при нарушении функции почек
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
EP2257292B1 (fr) Therapie avec une combinaison zn/trimethoprime
JPS5849315A (ja) 抗腫瘍剤
US6620816B2 (en) Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
JPH0859485A (ja) ３ーオキシゲルミルプロピオン酸化合物を主成分とするメイラード反応阻害剤
CA2138957A1 (fr) Remede contre les maladies intestinales inflammatoires
JP2836797B2 (ja) 血小板減少症およびまたは白血球減少症治療剤
EP0082667A1 (fr) Compositions pharmaceutiques
JPH08165236A (ja) 下痢の予防及び治療剤
JP2538422B2 (ja) ５―フルオロウラシル類により起こる炎症の発生を抑制する非注射剤形態の制癌剤
RU2201230C1 (ru) Лекарственное средство флузол, обладающее противогрибковым действием
JP3845307B2 (ja) 心筋梗塞治療薬
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
JPH09316004A (ja) 虚血に伴う組織損傷を減じる薬剤
JPH01216931A (ja) 血中尿酸濃度低減用治療剤
JPS6231689B2 (fr)
JPH01163122A (ja) 抗レトロウイルス剤
CZ33795A3 (en) Pharmaceutical preparation for preventing formation of cancer metastases in liver, pharmaceutical preparation for treating cancer of liver and process for preparing such pharmaceutical
JP2003300888A (ja) 抗腫瘍効果増強剤

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20100104